Compile Data Set for Download or QSAR
maximum 50k data
Found 57 Enz. Inhib. hit(s) with all data for entry = 2870
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  43nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25616(2,6-Disubstituted Pyrazine, 79 | N-{4-[(6-{[3-(1,3...)
Affinity DataIC50:  310nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25612(2,6-Disubstituted Pyrazine, 70 | N-[5-({6-[(3,4,5-...)
Affinity DataIC50:  410nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25613(2,6-Disubstituted Pyrazine, 76 | N-[4-({6-[(3,4,5-...)
Affinity DataIC50:  560nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25614(2,6-Disubstituted Pyrazine, 77 | N-{5-[(6-{[3-(1,3...)
Affinity DataIC50:  650nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25570(2,6-Disubstituted Pyrazine, 13 | 4-{6-[(3,4,5-trim...)
Affinity DataIC50:  1.10E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25580(2,6-Disubstituted Pyrazine, 26 | 6-(naphthalen-1-y...)
Affinity DataIC50:  1.20E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25569(1-phenyl-3-(4-{6-[(3,4,5-trimethoxyphenyl)amino]py...)
Affinity DataIC50:  1.20E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25609(2,6-Disubstituted Pyrazine, 73 | 6-{[(1E)-1-(hydro...)
Affinity DataIC50:  1.40E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25590(2,6-Disubstituted Pyrazine, 53 | 6-(quinolin-4-ylo...)
Affinity DataIC50:  1.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25615(2,6-Disubstituted Pyrazine, 78 | N-[5-({6-[(3-oxo-...)
Affinity DataIC50:  2.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25562(2,6-Disubstituted Pyrazine, 4 | 6-(pyridin-4-yl)-N...)
Affinity DataIC50:  2.90E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25568(2,6-Disubstituted Pyrazine, 10 | 4-{6-[(3,4,5-trim...)
Affinity DataIC50:  3.00E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25561(2,6-Disubstituted Pyrazine, 1 | CHEMBL200114 | N-(...)
Affinity DataIC50:  3.50E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25593(2,6-Disubstituted Pyrazine, 56 | 6-(isoquinolin-5-...)
Affinity DataIC50:  3.80E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25564(2,6-Disubstituted Pyrazine, 6 | 3-{6-[(3,4,5-trime...)
Affinity DataIC50:  4.00E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25575(2,6-Disubstituted Pyrazine, 21 | 2-N-(pyridin-4-yl...)
Affinity DataIC50:  4.70E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25577(2,6-Disubstituted Pyrazine, 23 | 4-({6-[(3,4,5-tri...)
Affinity DataIC50:  4.90E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25604(2,6-Disubstituted Pyrazine, 67 | N-[4-({6-[(3,4,5-...)
Affinity DataIC50:  5.50E+3nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25587(2,6-Disubstituted Pyrazine, 32 | 6-(1H-indol-4-ylo...)
Affinity DataIC50:  7.40E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25588(2,6-Disubstituted Pyrazine, 12 | 3-{6-[(3,4,5-trim...)
Affinity DataIC50:  9.80E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25585(2,6-Disubstituted Pyrazine, 30 | 6-(naphthalen-1-y...)
Affinity DataIC50:  9.80E+3nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25591(2,6-Disubstituted Pyrazine, 54 | 6-(quinolin-5-ylo...)
Affinity DataIC50:  1.00E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25599(2,6-Disubstituted Pyrazine, 62 | 6-(2-phenylphenox...)
Affinity DataIC50:  1.00E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25607(2,6-Disubstituted Pyrazine, 71 | 6-{3-[(1Z)-1-(hyd...)
Affinity DataIC50:  1.10E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25578(2,6-Disubstituted Pyrazine, 24 | 2-N-(3-fluorophen...)
Affinity DataIC50:  1.20E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25603(2,6-Disubstituted Pyrazine, 66 | N-[3-({6-[(3,4,5-...)
Affinity DataIC50:  1.30E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25576(2,6-Disubstituted Pyrazine, 22 | N-[3-({6-[(3,4,5-...)
Affinity DataIC50:  1.40E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25567(2,6-Disubstituted Pyrazine, 9 | ethyl 3-{6-[(3,4,5...)
Affinity DataIC50:  1.40E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25583(2,6-Disubstituted Pyrazine, 28 | 6-(pyridin-4-ylox...)
Affinity DataIC50:  1.60E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25573(2,6-Disubstituted Pyrazine, 19 | N-[4-({6-[(3,4,5-...)
Affinity DataIC50:  1.60E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25574(2,6-Disubstituted Pyrazine, 20 | 2-N-phenyl-6-N-(3...)
Affinity DataIC50:  1.60E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25565(2,6-Disubstituted Pyrazine, 7 | 4-{6-[(3,4,5-trime...)
Affinity DataIC50:  1.80E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25596(2,6-Disubstituted Pyrazine, 59 | 4-({6-[(3,4,5-tri...)
Affinity DataIC50:  1.80E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25586(2,6-Disubstituted Pyrazine, 31 | 6-(5,6,7,8-tetrah...)
Affinity DataIC50:  1.80E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25579(2,6-Disubstituted Pyrazine, 25 | 2-N-(4-fluorophen...)
Affinity DataIC50:  1.90E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25605(1-[3-({6-[(3,4,5-trimethoxyphenyl)amino]pyrazin-2-...)
Affinity DataIC50:  1.90E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25563(2,6-Disubstituted Pyrazine, 5 | 6-(pyridin-3-yl)-N...)
Affinity DataIC50:  2.20E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25598(2,6-Disubstituted Pyrazine, 61 | 6-({6-[(3,4,5-tri...)
Affinity DataIC50:  2.20E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25572(N-(3-{5-[(3,4,5-trimethoxyphenyl)amino]pyridin-3-y...)
Affinity DataIC50:  2.60E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25566((4-{6-[(3,4,5-trimethoxyphenyl)amino]pyrazin-2-yl}...)
Affinity DataIC50:  2.60E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25608(2,6-Disubstituted Pyrazine, 72 | 6-{4-[(1E)-1-(hyd...)
Affinity DataIC50:  2.60E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25594(2,6-Disubstituted Pyrazine, 57 | 5-({6-[(3,4,5-tri...)
Affinity DataIC50:  2.90E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25592(2,6-Disubstituted Pyrazine, 55 | 6-(quinolin-6-ylo...)
Affinity DataIC50:  2.90E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25582(2,6-Disubstituted Pyrazine, 27 | 6-phenoxy-N-(3,4,...)
Affinity DataIC50:  3.10E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25606(1-[4-({6-[(3,4,5-trimethoxyphenyl)amino]pyrazin-2-...)
Affinity DataIC50:  3.40E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25602(2,6-Disubstituted Pyrazine, 65 | 6-(3-chlorophenox...)
Affinity DataIC50:  3.60E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25589(2,6-Disubstituted Pyrazine, 52 | 7-({6-[(3,4,5-tri...)
Affinity DataIC50:  4.40E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25584(2,6-Disubstituted Pyrazine, 29 | 6-(pyridin-3-ylox...)
Affinity DataIC50:  4.50E+4nMpH: 7.2 T: 2°CAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase B-raf [V600E](Homo sapiens (Human))
Cancer Research Uk Centre For Cancer Therapeutics

LigandPNGBDBM25600(2,6-Disubstituted Pyrazine, 63 | 6-(2-fluorophenox...)
Affinity DataIC50:  4.50E+4nMAssay Description:BRAF kinase activity was quantified using a DELFIA-based MEK1 phosphorylation assay. IC50 values were derived from the sigmoidal dose-response curves...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: